Ravicti (glycerol phenylbutyrate): Reviews and patient testimonials
Back to the list of medications
Medication indications
Ravicti 1.1 gml oral liquid
RAVICTI is indicated for use as adjunctive therapy for chronic management of adult and paediatric patients ≥2 months of age with urea cycle disorders (UCDs) including deficiencies of carbamoyl phosphate synthetase I (CPS), ornithine carbamoyltransferase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase I (ARG) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (HHH) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.
RAVICTI must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).
Route of administration: Oral
Molecule: glycerol phenylbutyrate
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.